NASDAQ:ORMP
Oramed Pharmaceuticals, Inc.
(NASDAQ:ORMP)
8.77
+0.22
(+2.57%)
As of 2022-08-08 Close (EST)
| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
ACTION
TICKER
SHARES
STATUS
Fund28 • Aalto Investment management game (Fall 2021) • Nov 2021
Based on the long-short momentum strategy (with 30 long and 10 short positions), ORMP is in the top 30 performing companies in Nasdaq available on this platform. Short-term and long-term momentum show a positive trend, therefore we buy the stock.
ACTION
TICKER
SHARES
STATUS
Mastersofmomentum • Aalto Investment management game (Fall 2021) • Nov 2021
ORMP: Top performer of 1 year. Strategy: Long position momentum with 1/3 weight on 1y, 6mo, and 3mo performance categories.. 1,8x leverage.
ACTION
TICKER
SHARES
STATUS
onefundtorulethemall • Aalto Investment Management Game (Fall 2020) • Feb 2021
Automatic trade executed by Stockfuse to ensure margin compliance.
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS